Century Therapeutics to Participate in Upcoming Investor Conferences in March

Core Viewpoint - Century Therapeutics is advancing its pipeline of induced pluripotent stem cell (iPSC)-derived cell therapies aimed at treating autoimmune diseases and cancer, with a focus on expanding patient access through innovative technology [2]. Company Overview - Century Therapeutics (NASDAQ: IPSC) specializes in developing iPSC-derived cell therapies targeting autoimmune diseases, including type 1 diabetes, and cancer [2]. - The company utilizes its proprietary immune evasion engineering technology, Allo-Evasion™, to enhance the effectiveness of its therapies [2]. - Century aims to provide off-the-shelf cell therapies that improve patient access and offer advantages over existing treatments [2]. Upcoming Events - Century Therapeutics will participate in the TD Cowen 46th Annual Health Care Conference on March 4, 2026, with a fireside chat scheduled for 9:50 a.m. ET in Boston, MA [3]. - The company will also be present at the Leerink Partners Global Healthcare Conference on March 10, 2026, with a fireside chat at 4:20 p.m. ET in Miami, FL [3]. - Live webcasts of these presentations will be available on the company's Investors page, with archived replays accessible for at least 30 days [1].